Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024312 (
lymphopenia
)
4,859
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phytohemagglutinin (PHA) elicited expression of
peroxisome proliferator-activated receptor gamma
(
PPARgamma
) in primary human T cells via the PPARgamma3 promoter, as shown by reverse transcription-polymerase chain reaction. Electrophoretic mobility shift assay demonstrated no correlation between
PPARgamma
expression and its activation. However, addition of specific
PPARgamma
agonists such as ciglitazone or 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) for 1 h following PHA pretreatment provoked
PPARgamma
activation verified by supershift analysis. Taking the proapoptotic properties of
PPARgamma
into consideration, we analyzed induction of apoptosis in activated T cells in response to
PPARgamma
agonists. Cells exposed to
PPARgamma
agonists alone revealed minor cell death compared with controls, whereas treatment with 15d-PGJ(2) or ciglitazone for 4 h subsequent to PHA stimulation significantly increased cell demise, which was attenuated by the pan-caspase inhibitor zVAD, pointing to apoptosis as the underlying mechanism. These data may be relevant for pathophysiological conditions accompanied with
lymphopenia
of T cells under conditions such as sepsis.
...
PMID:Activation-induced PPARgamma expression sensitizes primary human T cells toward apoptosis. 1271 82
In the last two decades, extensive research failed to significantly improve the outcome of patients with sepsis. In part, this drawback is based on a gap in our knowledge about molecular mechanisms understanding the pathogenesis of sepsis. During sepsis, T cells are usually depleted. Recent studies in mice and human cells suggested a role of the
peroxisome proliferator-activated receptor gamma
(
PPARgamma
) in provoking apoptosis in activated T lymphocytes. Therefore, we studied whether expression/activation of
PPARgamma
might contribute to T cell death during sepsis. We observed
PPARgamma
up-regulation in T cells of septic patients. In contrast to controls,
PPARgamma
expressing cells from septic patients responded with apoptosis when exposed to
PPARgamma
agonists. Cell demise was attenuated by SR-202, a synthetic
PPARgamma
antagonist, and specificity was further verified by excluding a proapoptotic response to a PPARalpha agonist. We propose that up-regulation of
PPARgamma
sensitizes T cells of septic patients to undergo apoptosis.
PPARgamma
activation in T cells requires an exogenous
PPARgamma
agonist, which we identified in sera of septic patients. Septic sera were used to study reporter gene expression containing a PPAR-responsive element. We conclude that
PPARgamma
plays a significant role in T cell apoptosis, contributing to lymphocyte loss in sepsis. Thus, inhibition of
PPARgamma
may turn out to be beneficial for patients suffering from
lymphopenia
during sepsis.
...
PMID:Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis. 1638 Jun 2